Extended pharmacologic prophylaxis after colon cancer surgery is associated with improved overall and cancer-specific survival. Results suggest a potential anti-neoplastic effect from heparin derivatives in preventing post-surgical venous thromboembolism. A large database study of 20,102 patients showed significantly higher survival rates in patients who received extended prophylaxis. Multivariable analysis demonstrated a reduced risk of death with prophylaxis, supporting its use for improving outcomes in colon cancer patients.
Journal Article by Booth A, Brinton D (…) Curran T et 6 al. in Ann Surg
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.